Firefly Neuroscience — raw details

Highlights

IIA supported (ever)1 patentProfile claimed by owner

About

Measuring Brain Health

Firefly Neuroscience’s Brain Network Analytics (BNA™) technology provides an objective assessment of cognition (brain function). It records and compares how a brain functions to an FDA-cleared, normative, age-matched database using AI and advanced signal processing.

This allows clinicians and their patients to make informed, objective therapy and disease management decisions and track changes over time. Firefly Neuroscience takes the guesswork and subjectivity out of managing mental illnesses and cognitive disorders.

Identity

Name	Firefly Neuroscience
Slug	elminda
Former names	elminda
Type / kind	startup
Crunchbase ID	elminda
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6YwK4IDA

Status

Status	active
Status reason	Public on NASDAQ on Nov, 2021;
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Herzliya
HQ address	Arieh Shenkar St 1, Hertsliya, Israel

Web & social

Website	https://fireflyneuro.com/
Careers page	https://fireflyneuro.com/careers
LinkedIn	https://www.linkedin.com/company/2531441
Twitter / X	https://twitter.com/whatsyourbna

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesDigital HealthcareMedical Decision Support

Technologies

Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders

Business models

B2B2C

Funding

Total raised	$82.6M
Current stage	Public
Market cap	$11.8M

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}